BACKGROUND: Electroconvulsive therapy (ECT) has been used as an effective treatment option in severe and treatment resistant cases of depression for decades. However the mode of action of ECT is still not fully understood. Advances in neuroimaging created new possibilities to understand the functional changes of the human brain. METHODS: Literature review of studies assessing possible changes in cerebral glucose metabolism pre- and post-ECT by PET, identified by PubMed. RESULTS: Studies were limited by small sample size, inhomogeneous study population with uni- and bipolar depressive patients and methodological inconsistencies. Despite considerable variance, reduction in glucose metabolism after ECT in bilateral anterior and posterior frontal areas represented the most consistent findings. CONCLUSIONS: Future research into this issue should include larger and more consistent cohorts of patients. Assessing clinical improvement of depression after ECT should allow to correlate changes in brain glucose metabolism with functional scores. Follow up PET scans after six or twelve months should be performed to test if changes in brain metabolism are persistent.
BACKGROUND: Electroconvulsive therapy (ECT) has been used as an effective treatment option in severe and treatment resistant cases of depression for decades. However the mode of action of ECT is still not fully understood. Advances in neuroimaging created new possibilities to understand the functional changes of the human brain. METHODS: Literature review of studies assessing possible changes in cerebral glucose metabolism pre- and post-ECT by PET, identified by PubMed. RESULTS: Studies were limited by small sample size, inhomogeneous study population with uni- and bipolar depressivepatients and methodological inconsistencies. Despite considerable variance, reduction in glucose metabolism after ECT in bilateral anterior and posterior frontal areas represented the most consistent findings. CONCLUSIONS: Future research into this issue should include larger and more consistent cohorts of patients. Assessing clinical improvement of depression after ECT should allow to correlate changes in brain glucose metabolism with functional scores. Follow up PET scans after six or twelve months should be performed to test if changes in brain metabolism are persistent.
Authors: Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Ruiliang Wang; Dave Alexoff; Jean Logan; Christopher Wong; Kith Pradhan; Elisabeth C Caparelli; Yeming Ma; Millard Jayne Journal: Neuroimage Date: 2010-02-13 Impact factor: 6.556
Authors: Marina López-Solà; Jesus Pujol; Rosa Hernández-Ribas; Ben J Harrison; Oren Contreras-Rodríguez; Carles Soriano-Mas; Joan Deus; Héctor Ortiz; José M Menchón; Julio Vallejo; Narcís Cardoner Journal: Neuropsychopharmacology Date: 2010-07-28 Impact factor: 7.853
Authors: C C Abbott; T Jones; N T Lemke; P Gallegos; S M McClintock; A R Mayer; J Bustillo; V D Calhoun Journal: Transl Psychiatry Date: 2014-11-18 Impact factor: 6.222
Authors: Liam Trevithick; R Hamish McAllister-Williams; Andrew Blamire; Tim Branton; Ross Clark; Darragh Downey; Graham Dunn; Andrew Easton; Rebecca Elliott; Clare Ellwell; Katherine Hayden; Fiona Holland; Salman Karim; Jo Lowe; Colleen Loo; Rajesh Nair; Timothy Oakley; Antony Prakash; Parveen K Sharma; Stephen R Williams; Ian M Anderson Journal: BMC Psychiatry Date: 2015-10-21 Impact factor: 3.630
Authors: Christopher C Abbott; Nicholas T Lemke; Shruti Gopal; Robert J Thoma; Juan Bustillo; Vince D Calhoun; Jessica A Turner Journal: Front Psychiatry Date: 2013-03-01 Impact factor: 4.157
Authors: M Argyelan; T Lencz; S Kaliora; D K Sarpal; N Weissman; P B Kingsley; A K Malhotra; G Petrides Journal: Transl Psychiatry Date: 2016-04-26 Impact factor: 6.222